NCT02881814

Brief Summary

Introduction: Physiotherapist usually uses a clinical examination, including auscultation, an analysis of blood gasses and chest imaging to determine the indication for chest physiotherapy, to choose the treatment protocol and evaluate the efficacy of the management. Lung ultrasound (LUS) presents greater accuracy than chest X-ray in the diagnosis of lung deficiencies interesting the physiotherapist. So, it could allow the physiotherapist to determine the indication for chest physiotherapy and thus avoid unnecessary or inappropriate treatments. No study has evaluated the impact of LUS on clinical decisions in chest physiotherapy in ICU patients. Objective: To evaluate the impact of using the results of lung and diaphragm US on clinical decisions in chest physiotherapy in hypoxemic patients hospitalized in ICU. Method: The physiotherapist carries out a clinical examination and analyses the complementary tests (chest X-ray, chest CT-scan and blood gasses if available). Following the examination, he will put forward one or several hypotheses concerning the respiratory deficiency and will confirm or not the indication for chest physiotherapy. If respiratory physiotherapy is indicated, the physiotherapist will specify the protocol. A lung and diaphragm US will be done following the evaluation of the clinical physiotherapist, and will make it possible to answer the question: are the results of the lung and diaphragm US compatible with the hypotheses put forward? The LUS report will be given to the clinical physiotherapist. He will specify the respiratory physiotherapy protocol according to the results of the US-scan. The modification of the clinical decision will be assessed with the Net Reclassification Index (NRI). Expected results: We expect that decisions for chest physiotherapy will be modified by LUS. The expected benefit for patients is therefore that they will be given a chest physiotherapy protocol that is better suited to the type of respiratory deficiency they are suffering from.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
153

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2017

Longer than P75 for not_applicable

Geographic Reach
2 countries

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 29, 2016

Completed
8 months until next milestone

Study Start

First participant enrolled

May 2, 2017

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 18, 2020

Completed
3.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 14, 2024

Completed
Last Updated

September 13, 2023

Status Verified

September 1, 2023

Enrollment Period

3.6 years

First QC Date

August 24, 2016

Last Update Submit

September 11, 2023

Conditions

Keywords

Lung ultrasoundChest physiotherapyDecision-making processDiagnostic

Outcome Measures

Primary Outcomes (1)

  • Net Reclassification Index (NRI)

    Agreement (yes/no) between the lung and diaphragm US diagnosis and the clinical diagnosis and modification (yes/no) of the chest physiotherapy protocol

    Hour 1

Secondary Outcomes (2)

  • Prediction of duration of mechanical ventilation

    Final study visit

  • Prediction of mortality

    Final study visit

Study Arms (2)

Lung ultrasound and clinical decision

EXPERIMENTAL

Clinical assessment and choice of chest physiotherapy treatmetn performed by the clinical physiotherapist, followed by a comprehensive lung and diaphragm ultrasonography. After ultrasonography, the clinical physiotherapist is asked what CPT treatment he was going finally to implement, and explain the reasons for change, if any.

Diagnostic Test: Lung and diaphragm ultrasound

Mechanically ventilated patients

EXPERIMENTAL

In case of mechanically ventilated patient at St. Vincent Hospital (Sydney, Australia), LUS scan will be performed immediately following intubation. Additionnal LUS scans will be performed 72h after intubation and Immediately prior to or following extubation.

Diagnostic Test: Lung and diaphragm ultrasoundDiagnostic Test: Lung and diaphragm ultrasound in MV patients

Interventions

The ultrasound physiotherapist/operator performs a lung and diaphragm ultrasound. He is blinded to the patient's status and clinical physiotherapist examination. He/she is not involved in patient management or patient clinical decision-making. The ultrasound findings are recorded in the LUS report. The LUS report is reported to the clinical physiotherapist and to the intensivist. The ultrasound diagnosis(es) is recorded.

Lung ultrasound and clinical decisionMechanically ventilated patients

In case of mechanically ventilated patient at St. Vincent Hospital (Sydney, Australia), LUS scan will be performed immediately following intubation. Additionnal LUS scans will be performed 72h after intubation and Immediately prior to or following extubation.

Mechanically ventilated patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hypoxemia(SpO2/FiO2\< 315 (15))(indication for chest physiotherapy)(cf. annexe 1);
  • Medical prescription for chest physiotherapy;
  • First session of chest physiotherapy;
  • Chest X-ray\<12h available;
  • Physiotherapist/operator qualified in LUS available;
  • Patient's consent.

You may not qualify if:

  • Presence of a contra-indication for chest physiotherapy;
  • Absence of hypoxemia;
  • Absence of a prescription for chest physiotherapy;
  • Absence of a chest X-ray \< 12h from the time of physiotherapy assessment;
  • Physiotherapist/operator qualified in LUS not available;
  • Lung and diaphragm US not possible (surgical emphysema, dressing, scarring, drains etc.);
  • Refusal of the patient or a relative to participate in the study;
  • Patients to be discharged on the day of the study;
  • Patients in palliative care;
  • Withdrawal/limitations of medical care with impending death.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

St Vincent's Hospital

Sydney, NSW2010, Australia

Location

CHU de Dijon

Dijon, 21000, France

Location

Hôpital Forcilles

Férolles-Attilly, 77150, France

Location

Groupe Hospitalier Paris Saint Joseph

Paris, Île-de-France Region, 75014, France

Location

Related Publications (4)

  • Xirouchaki N, Georgopoulos D. Impact of lung ultrasound on clinical decision making in critically ill patients: response to O'Connor et al. Intensive Care Med. 2014 Jul;40(7):1063. doi: 10.1007/s00134-014-3316-6. Epub 2014 May 6. No abstract available.

  • Le Neindre A, Mongodi S, Philippart F, Bouhemad B. Thoracic ultrasound: Potential new tool for physiotherapists in respiratory management. A narrative review. J Crit Care. 2016 Feb;31(1):101-9. doi: 10.1016/j.jcrc.2015.10.014. Epub 2015 Oct 26.

  • Leech M, Bissett B, Kot M, Ntoumenopoulos G. Lung ultrasound for critical care physiotherapists: a narrative review. Physiother Res Int. 2015 Jun;20(2):69-76. doi: 10.1002/pri.1607. Epub 2014 Dec 29.

  • Le Neindre A, Hansell L, Wormser J, Gomes Lopes A, Diaz Lopez C, Romanet C, Choukroun G, Nguyen M, Philippart F, Guinot PG, Buscher H, Bouhemad B, Ntoumenopoulos G. Thoracic ultrasound influences physiotherapist's clinical decision-making in respiratory management of critical care patients: a multicentre cohort study. Thorax. 2023 Feb;78(2):169-175. doi: 10.1136/thoraxjnl-2021-218217. Epub 2022 Mar 23.

MeSH Terms

Conditions

Critical IllnessRespiration DisordersDisease

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsRespiratory Tract Diseases

Study Officials

  • Belaid Bouhemad, MD, PhD

    Centre Hospitalier Universitaire Dijon

    STUDY DIRECTOR
  • Aymeric Le Neindre, PhD

    Hopital Forcilles

    PRINCIPAL INVESTIGATOR
  • George Ntoumenopoulos, PhD

    St Vincent's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2016

First Posted

August 29, 2016

Study Start

May 2, 2017

Primary Completion

November 18, 2020

Study Completion

April 14, 2024

Last Updated

September 13, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will share

The data that support the findings of this study will be openly available in "figshare".

Shared Documents
SAP, ANALYTIC CODE
Time Frame
At publication.
Access Criteria
The data that support the findings of this study will be openly available

Locations